Table 1.

Relationship between JARID1B protein expression and clinicopathological features in CRC patients

Parameters	Total 54a	Relative JARID1B protein expressionb	P value
Gender			0.53
Male	36	2.11 ± 0.85
Female	18	2.34 ± 0.89
Age (years)			0.71
≤ 60	20	2.14 ± 0.93
> 60	34	2.22 ± 0.83
Tumor size (cm)			0.00**
< 5	23	1.61 ± 0.80
≥ 5	31	2.62 ± 0.62
Preoperative CEA level			0.00**
< 5 ng/mL	40	1.86 ± 0.72
≥ 5 ng/mL	15	3.13 ± 0.41
Histologic grade			0.98
well differentiated	42	2.17 ± 0.89
poorly differentiated	12	2.26 ± 0.80
T classification			0.00**
T1 + T2	17	1.19 ± 0.54
T3 + T4	37	2.65 ± 0.53
TNM stage			0.38
I	4	1.57 ± 0.55
II	14	2.28 ± 1.02
III	28	2.18 ± 0.88
IV	8	2.37 ± 0.51
Lymphatic invasion			0.52
Negative	21	2.12 ± 0.91
Positive	33	2.24 ± 0.84
Distant metastasis			0.88
Negative	45	2.16 ± 0.92
Positive	9	2.33 ± 0.50

^a54 fresh tissue samples from June 2018 to December 2018, ^bprotein level in Tumor tissues/protein level in Adjacent tissues (mean ± SD),**p ≤ 0.01